CY2013 Q2
Showing 1 to 17 of 17 rows
Loading, please wait
Company
|
Value
|
End Date
|
SEC Filing
|
---|---|---|---|
ARES COMMERCIAL REAL ESTATE CORPORATION | $8,400,000.00 | 2013-06-21 | View |
Bausch Health Companies Inc. | $31,000,000.00 | 2013-06-24 | View |
CASCADIAN THERAPEUTICS, INC. | $500,000.00 | 2013-07-01 | View |
EMERGE ENERGY SERVICES LP | $10,600,000.00 | 2013-05-20 | View |
EXACT SCIENCES CORPORATION | $4,800,000.00 | 2013-06-21 | View |
EyePoint Pharmaceuticals, Inc. | $890,000.00 | 2013-07-31 | View |
IDENTIV, INC. | $800,000.00 | 2013-08-14 | View |
INSMED INCORPORATED | $4,700,000.00 | 2013-07-22 | View |
INTELLIPHARMACEUTICS INTERNATIONAL INC. | $467,989.00 | 2013-07-31 | View |
OMEROS CORPORATION | $39,000.00 | 2013-05-31 | View |
ROI Acquisition Corp. II | $0.00 | 2013-06-30 | View |
ROSE ROCK MIDSTREAM, L.P. | $6,400,000.00 | 2013-08-14 | View |
Rosetta Genomics Ltd. | $213,000.00 | 2013-05-22 | View |
TEARLAB CORP | $3,100,000.00 | 2013-07-30 | View |
TRUETT-HURST, INC. | $-1,600,000.00 | 2013-06-30 | View |
Xtant Medical Holdings, Inc. | $400,000.00 | 2013-06-10 | View |
YuMe Inc | $2,900,000.00 | 2013-08-12 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations